• Generic Brand NameBosutris
  • API:   Bosutinib
  • Packaging: Tablets
  • Strength: 100 mg, 400 mg and 500 mg
Get Price


Bosutinib Uses:

The medicine Bosutinib is a kinase inhibitor recommended for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CML) with resistance or intolerance to prior therapy and Chronic phase, accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance or intolerance to initial therapy.


Bosutinib tablets come in 100 mg, 400 mg, and 500 mg to administer orally via the mouth. The recommended dose and schedule of Bosutinib is 500 mg orally once daily with food. Continue treatment with Bosutinib until disease progression or patient intolerance. If a dose is missed beyond 12 hours, the patient should skip the dose and take the usually prescribed amount the following day.

Side Effects:

The most common side effects of Bosutinib are:

  • Diarrhea
  • Nausea
  • Thrombocytopenia
  • Vomiting
  • abdominal pain
  • Rash
  • Anemia
  •  Pyrexia
  •  Fatigue
Warnings and Precautions:
  • There are reports of gastrointestinal toxicity such as diarrhea, nausea, vomiting, and abdominal pain in patients receiving the medicine Bosutinib. One should monitor and manage patients using standards of care, including antidiarrheals, antiemetics, and fluid replacement. To manage gastrointestinal toxicity, withhold, dose reduce, or discontinue Bosutinib as necessary.

  • Thrombocytopenia, anemia, and neutropenia occur with treatment with Bosutinib. Patients with CML who are receiving Bosutinib tablets should have a complete blood count performed weekly for the first month and then monthly thereafter, or as clinically indicated. To manage myelosuppression, withhold, dose reduce, or discontinue the medicine as necessary.

  • Cases of Hepatic toxicity are reported recently in patients administered Bosutinib 100 mg, 400 mg, and 500 mg. One should perform monthly hepatic enzyme tests for the first three months of treatment with Bosutinib and as clinically indicated. In patients with transaminase elevations, monitor liver enzymes more frequently. Withhold, dose reduce, or discontinue Bosutinib as needed.

  • The medicine Bosutinib can cause fetal harm when administered to a pregnant woman. Females of reproductive potential should be advised to avoid pregnancy while being treated with Bosutinib. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.

More Info


One should store the medicine Bosutinib at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

Availability in India:

The Indian Pharma helps connect buyers with suppliers who can ship Bosutinib at the global level as per buyers’ needs. The Indian Pharma provides a guarantee of quality and delivery for the Bosutinib Tablets.

Buying Procedure:

In order to buy Bosutris 400 (Bosutinib), you can contact us at our Toll-free number 1800 889 1064, or on WhatsApp at +919310090915 or Email to us along with your Identity Proof, Valid Prescription Letter, and Medical Reports.


Bosutinib is used to treat patients with Newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) and Chronic phase, accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance or intolerance to prior therapy.


When was Bosutinib approved by the FDA?

The medicine Bosutinib was approved by the FDA in September 2012.

What class of drug is Bosutinib?

Bosutinib belongs to the class of kinase inhibitors.

Is Bosutinib chemotherapy?

Bosutinib is a targeted therapy. Bosutinib inhibits the Bcr-Abl kinase that promotes CML; it is also an inhibitor of Src-family kinases including Src, Lyn, and Hck.

Where can I get Bosutinib at the best price?

In order to get the best Bosutinib price, always buy this medicinal product from a Pharmaceutical Wholesaler Company which is certified by higher authorities like WHO-GDP & ISO 9001:2008.

Can I get Bosutinib even if I am not based in India?

The Indian Pharma helps patients access or import Bosutinib, not approved in their home country against the legitimate prescription and in conformity with all local laws and regulations of their home country.

Is Bosutinib available in India?

Bosutinib is a prescription medicine that legally requires a medical prescription to be dispensed. The Indian Pharma can facilitate the supply of Bosutinib to all locations after fulfilling the legal requirement (if applicable). Please contact us via +91-8130290915 | TOLL-FREE Number: 1800-889-1064 or write us at to know the best price of Bosutinib in India.